NGM·Healthcare·$159M·#327 / 520 in Healthcare
QTRX Quanterix Corporation
36HIGH RISK
CATEGORY BREAKDOWN
GROWTH4
QUALITY39
STABILITY35
VALUATION99
GOVERNANCE34
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+2.4%
4
> 50% strong
Gross Margin
Revenue retained after direct costs
46.7%
65
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
8
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
12.6%
90
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.1x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
-77
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
6.2%
46
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+21.3%
9
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE QTRX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when QTRX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.